These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9191402)

  • 41. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.
    Fu XT; Bono CP; Woulfe SL; Swearingen C; Summers NL; Sinigaglia F; Sette A; Schwartz BD; Karr RW
    J Exp Med; 1995 Mar; 181(3):915-26. PubMed ID: 7869051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines.
    Kovats S; Whiteley PE; Concannon P; Rudensky AY; Blum JS
    Eur J Immunol; 1997 Apr; 27(4):1014-21. PubMed ID: 9130658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
    Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
    Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.
    Albrecht H; Cosman M; Ngu-Schwemlein M; Corzett M; Curran KW; Dolan C; Fang X; DeNardo SJ; DeNardo GL; Balhorn R
    Cancer Biother Radiopharm; 2007 Aug; 22(4):531-42. PubMed ID: 17803448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.
    Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM
    Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen processing and presentation by a mouse macrophage-like cell line expressing human HLA class II molecules.
    Daubenberger C; Lang B; Nickel B; Willcox N; Melchers I
    Int Immunol; 1996 Mar; 8(3):307-315. PubMed ID: 8671616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.
    Bontrop RE; Elferink DG; Otting N; Jonker M; de Vries RR
    J Exp Med; 1990 Jul; 172(1):53-9. PubMed ID: 1694228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection.
    Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A
    J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of in vitro immune responses in humans using T cell clones and monoclonal antibodies].
    Ogasawara K
    Hokkaido Igaku Zasshi; 1984 May; 59(3):346-55. PubMed ID: 6207087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells.
    Martinez-Soria E; Siegrist CA; Mach B
    Int Immunol; 1996 Apr; 8(4):543-9. PubMed ID: 8671641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses.
    Wu S; Maslanka K; Gorski J
    J Immunol; 1997 Apr; 158(7):3221-6. PubMed ID: 9120277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
    Huang SK; Zwollo P; Marsh DG
    Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA-DR and -DQ epitopes and monoclonal antibody specificity.
    Marsh SG; Bodmer JG
    Immunol Today; 1989 Sep; 10(9):305-12. PubMed ID: 2480137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigen presentation mediated by recycling of surface HLA-DR molecules.
    Pinet V; Vergelli M; Martin R; Bakke O; Long EO
    Nature; 1995 Jun; 375(6532):603-6. PubMed ID: 7540726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.